GRIN2A p.Phe652Val
c.1954T>G · rs397518471 · VCV88733
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9992 | likely pathogenic ✓ concordant with ClinVar · top 4% in GRIN2A |
|---|---|---|
| REVEL | 0.751 | pathogenic-leaning |
| SaProt | LLR -14.36 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
| Constraint at this position | ||
| Conservation | phyloP 11 | GERP 1.9, phastCons 1 |
| Regional constraint | o/e 0.06 | constrained · MANE · 79 bp · p 6.2e-08 · regional, not allelic |
| Overall | ||
| CADD | 29.8 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- GRIN2A
- Protein
- p.Phe652Val
- Coding
- c.1954T>G
- MANE Select
- NM_001134407
- dbSNP
- rs397518471
- Type
- single nucleotide variant
- Location
- chr16:9829476 (GRCh38)
- Gene constraint
- LOEUF 0.268 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 60.70 · 37 PDB
- Residue 652
- a UniProt-annotated variant site (in fesd; likely pathogenic; results in increased agonist potency and channel activation at lower glutamate and glycine concentrations compared to wild type channels; results in substantial alterations of channel gating properties and affects duration of channel open and closed states); an α-helix; a UniProt-annotated variant site (found in schizophrenia; uncertain significance; loss of function in ion transmembrane transport; the channel is not activated by glutamate)
Disease context
Landau-Kleffner syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Landau-Kleffner syndrome (Orphanet):
- Inheritance
- Autosomal dominant, Unknown
- Onset
- Childhood
- Prevalence
- 1-9 / 1 000 000 (Japan)
Similar variants
- GRIN2A c.1007+1G>A Pathogenic/Likely pathogenic ★★ same condition
- GRIN2A c.1007+1G>T Pathogenic ★★ same condition
- GRIN2A c.1123-2A>G Pathogenic/Likely pathogenic ★★ same condition
- GRIN2A c.1497+1G>T Pathogenic/Likely pathogenic ★★ same condition
- GRIN2A c.2007+1G>T Likely pathogenic ★★ same condition
- GRIN2A c.2168+1G>C Pathogenic/Likely pathogenic ★★ same condition
- GRIN2A c.415-2A>G Likely pathogenic ★★ same condition
- GRIN2A p.Ala548Pro Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/grin2a-p-phe652val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown